â– LECTURE OVERVIEW: Arsenic is a highly toxic metalloid whose clinical manifestations stem from its dual-action disruption of eukaryotic cellular respiration and ATP generation.
â– THE CHELATATIVE AND BIOCHEMICAL PATHWAYS:
1. Lipoic Acid Inactivation: Trivalent arsenic (arsenite, As3+) binds covalently to neighboring sulfhydryl (-SH) groups of dihydrolipoamide (lipoic acid). Lipoic acid is an essential, active catalytic prosthetic group for key mitochondrial multi-enzyme complexes: Pyruvate Dehydrogenase (PDH), Alpha-Ketoglutarate Dehydrogenase (a-KGDH), and Branched-Chain Alpha-Ketoacid Dehydrogenase (BCKDH).
2. Energy Crisis: Inhibiting these enzymes halts the entry of glycolytic products into the Citric Acid (Kreb's) Cycle and blocks the processing of branched-chain amino acids, completely shutting down oxidative phosphorylation and causing severe ATP depletion.
3. Glycolytic Uncoupling: Pentavalent arsenic (arsenate, As5+) acts as a metabolic structural analog to inorganic phosphate (PO4^3-). It substitutes for phosphate in the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) step of glycolysis, producing 1-arseno-3-phosphoglycerate, which hydrolyzes spontaneously without generating ATP.
4. Pyruvate Shunting: Pyruvate accumulates and is shunted into lactate, resulting in severe systemic lactic acidosis.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– CLINICAL CASE SUMMARY:
A 45-year-old patient presented with acute clinical deterioration. Aggressive initial stabilization, molecular monitoring, and specialized pathology screening confirmed the classic disease hallmarks.
[HY-BOARD-1036]
🌟 Dynamic Clinical Key:
Arsenic poisoning clinically presents as a constellation of garlic breath, severe vomiting, profuse watery and bloody diarrhea, QTc interval prolongation, and painful peripheral neuropathy. Chronic exposure leads to cutaneous hyperkeratosis and hyperpigmentation (raindrop pigmentation) and increases the risk of squamous cell carcinoma of the skin and lung. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Clinical vigilance during early presentation prevents progression along the severe outcome pathway.